Syndax Pharmaceuticals Inc
NASDAQ:SNDX

Watchlist Manager
Syndax Pharmaceuticals Inc Logo
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
Watchlist
Price: 9.26 USD 4.04% Market Closed
Market Cap: 796.8m USD

Intrinsic Value

SNDX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one SNDX stock under the Base Case scenario is 16.83 USD. Compared to the current market price of 9.26 USD, Syndax Pharmaceuticals Inc is Undervalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SNDX Intrinsic Value
16.83 USD
Undervaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Syndax Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for SNDX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare SNDX to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SNDX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Syndax Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Syndax Pharmaceuticals Inc

Current Assets 548.8m
Cash & Short-Term Investments 516.3m
Receivables 21.5m
Other Current Assets 11m
Non-Current Assets 92m
Long-Term Investments 89.9m
PP&E 1.8m
Other Non-Current Assets 217k
Efficiency

Free Cash Flow Analysis
Syndax Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Syndax Pharmaceuticals Inc

Revenue
43.7m USD
Cost of Revenue
-17.7m USD
Gross Profit
26m USD
Operating Expenses
-369.7m USD
Operating Income
-343.7m USD
Other Expenses
12.5m USD
Net Income
-331.2m USD
Fundamental Scores

SNDX Profitability Score
Profitability Due Diligence

Syndax Pharmaceuticals Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

15/100
Profitability
Score

Syndax Pharmaceuticals Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

SNDX Solvency Score
Solvency Due Diligence

Syndax Pharmaceuticals Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
50/100
Solvency
Score

Syndax Pharmaceuticals Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SNDX Price Targets Summary
Syndax Pharmaceuticals Inc

Wall Street analysts forecast SNDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNDX is 35.98 USD with a low forecast of 17.17 USD and a high forecast of 53.55 USD.

Lowest
Price Target
17.17 USD
85% Upside
Average
Price Target
35.98 USD
289% Upside
Highest
Price Target
53.55 USD
478% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Syndax Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SNDX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SNDX Insider Trading
Buy and sell transactions by insiders

SNDX News

Other Videos
What is the Intrinsic Value of one SNDX stock?

The intrinsic value of one SNDX stock under the Base Case scenario is 16.83 USD.

Is SNDX stock undervalued or overvalued?

Compared to the current market price of 9.26 USD, Syndax Pharmaceuticals Inc is Undervalued by 45%.

Back to Top